Comorbidities Key to Serious Infections With IBD Treatment :

Older IBD patients with comorbidities are less likely to be hospitalized due to an infection if they are treated with vedolizumab or ustekinumab than with an anti-TNF agent, suggests a US study.

Related Keywords

New York , United States , Boston , Massachusetts , Danaj Lukin , Bharati Kochar , Colitis Foundation , Jill Roberts Center , Chleck Family Foundation , National Institutes Of Health , Theamerican Journal , Massachusetts General Hospital , Medscape Medical News , World Study , Older Adults With , Charlson Comorbidity Index , Inflammatory Bowel Disease , New York City , National Institutes , Chleck Family , Crohns Disease , Anti Tnf , Anti Tumor Necrosis Factor , Biologic Therapy , Ulcerative Colitis , Nflammatory Bowel Disease Ibd , Bd , Monoclonal Antibody , Etuximab , Ituximab , Hospitals , Inpatient Care , Clinical Research , Clinical Trials , Linical Studies , Healthcare And Medical Technology , Ealth And Medical Tech , Ealth And Med Tech , Ealth And Medical Technology , Immunocompromi ,